Cancer Cause and Prevention Research in Wisconsin
Cancer Cause and Prevention Research (93.393) awarded $60.6 million to recipients in Wisconsin in 30 grants from fiscal 2021 to 2025, 1.7% of the program's national total. University of Wisconsin System received the most, $48.4 million.
- Awarded in Wisconsin$60.6 million
- Awards30
- Share of the program1.7%
- Rank among states17th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 17 | $14.2 million |
| FY 2022 | 17 | $14.4 million |
| FY 2023 | 15 | $12.6 million |
| FY 2024 | 19 | $10.9 million |
| FY 2025 | 15 | $8.5 million |
Recipients in Wisconsin
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Wisconsin System | Colleges and universities | 18 | $48.4 million |
| The Medical College of Wisconsin, Inc. | Colleges and universities | 9 | $10.6 million |
| Voximetry Inc | Small businesses | 1 | $1.1 million |
| University of Wisconsin System | Colleges and universities | 1 | $462,320 |
| Society for Research on Nicotine & Tabacco Inc | Nonprofits | 1 | $25,000 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Wisconsin?
$60.6 million from fiscal 2021 to 2025, across 30 awards. Wisconsin ranks 17th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Wisconsin?
The largest recipient is University of Wisconsin System, with $48.4 million in 18 awards. Next are The Medical College of Wisconsin, Inc. and Voximetry Inc.
Can organizations in Wisconsin apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Wisconsin
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Special Education Grants to States
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program